C. Timke

发表

Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761.

Ute Wirkner, Peter Peschke, Peter E Huber, 2011, Neoplasia.

Blockade of TGF-beta signaling by the TGF β RI kinase Inhibitor LY 2109761 enhances radiation response and prolongs survival in glioblastoma

J. Debus, M. Röhrich, A. Martin-Villalba, 2011 .

Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis

J. Debus, N. Nicolay, U. Wirkner, 2017, Journal of the National Cancer Institute.

Correlation of Patient-Related Factors and Dose-Volume Histogram Parameters with the Onset of Radiation Pneumonitis in Patients with Small Cell Lung Cancer

J. Debus, M. Bischof, P. Huber, 2010, Strahlentherapie und Onkologie.

Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer.

J. Debus, J. Weitz, W. Harms, 2007, International journal of radiation oncology, biology, physics.

Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.

J. Debus, J. Weitz, M. Eble, 2006, International journal of radiation oncology, biology, physics.

Intraoperative electron radiotherapy for the management of aggressive fibromatosis.

J. Debus, J. Weitz, M. Bischof, 2007, International journal of radiation oncology, biology, physics.

A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer

M. Koch, M. Büchler, J. Debus, 2011, BMC Cancer.

Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma.

J. Debus, J. Weitz, W. Harms, 2006, International journal of radiation oncology, biology, physics.

Intraoperative electron boost radiation followed by moderate doses of external beam radiotherapy in limb-sparing treatment of patients with extremity soft-tissue sarcoma.

J. Debus, J. Weitz, P. Huber, 2006, International journal of radiation oncology, biology, physics.

Final results of a phase II trial [PARC-Study ISRCTN56652283] for patients with primary inoperable locally advanced pancreatic cancer combining intensity modulated radiotherapy (IMRT) with cetuximab and gemcitabine

H. Friess, J. Debus, M. Büchler, 2008 .

Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)—Eudract number 2005–003911–63; NCT00311857

J. Debus, K. Herfarth, W. Wick, 2008 .

Cetuximab in combination with intensity modulated radiotherapy (IMRT) and gemcitabine for patients with locally advanced pancreatic cancer: A prospective phase II trial [PARC-Study ISRCTN56652283]

H. Friess, K. Herfarth, M. Büchler, 2007 .

Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis

J. Debus, P. Huber, F. Röder, 2016, Radiation Oncology.

Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer

J. Debus, N. Nicolay, P. Huber, 2014, Radiation oncology.

Intensity modulated radiotherapy (IMRT) in benign giant cell tumors -- a single institution case series and a short review of the literature

C. Thieke, J. Debus, M. Bischof, 2010, Radiation oncology.

Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8

N. Halama, D. Jäger, P. Rosenstiel, 2022, Science advances.

Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.

K. Schäkel, N. Halama, D. Jäger, 2013, Cancer cell.

Combination of Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor Inhibition Markedly Improves Radiation Tumor Therapy

J. Debus, A. Abdollahi, K. Weber, 2008, Clinical Cancer Research.

Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis

J. Debus, J. Werner, P. Huber, 2012, BMC Cancer.

Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer – PARC: study protocol [ISRCTN56652283]

H. Friess, J. Debus, K. Herfarth, 2005, BMC Cancer.

Reirradiation with intensity‐modulated radiotherapy in recurrent head and neck cancer

J. Debus, W. Schlegel, C. Thieke, 2011, Head & neck.

Local setup errors in image-guided radiotherapy for head and neck cancer patients immobilized with a custom-made device.

Christian Thieke, Rolf Bendl, Kristina Giske, 2011, International journal of radiation oncology, biology, physics.

Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer

J. Debus, C. Thieke, M. Bischof, 2011, Radiation oncology.

IMRT Reirradiation with Concurrent Cetuximab Immunotherapy in Recurrent Head and Neck Cancer

C. Thieke, J. Debus, M. Münter, 2010, Strahlentherapie und Onkologie.

Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC

J. Debus, J. Werner, A. Kopp-Schneider, 2012, BMC Cancer.

Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer

M. Koch, J. Debus, J. Weitz, 2011, BMC Cancer.

Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis

J. Debus, P. Huber, F. Röder, 2016, Radiation Oncology.

Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.

J. Debus, K. Herfarth, P. Helmbold, 2008, European journal of dermatology : EJD.

Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518)

S. Nill, U. Haberkorn, J. Debus, 2006, BMC Cancer.

LY2109761 Attenuates Radiation-Induced Pulmonary Murine Fibrosis via Reversal of TGF-β and BMP-Associated Proinflammatory and Proangiogenic Signals

U. Wirkner, P. Peschke, Kai Hauser, 2012, Clinical Cancer Research.

Cancer Therapy : Preclinical LY 2109761 Attenuates Radiation-Induced Pulmonary Murine Fibrosis via Reversal of TGF-b and BMP-Associated Proin fl ammatory and Proangiogenic Signals

U. Wirkner, P. Peschke, Kai Hauser, 2012 .

New Multileaf Collimator with a Leaf Width of 5 mm Improves Plan Quality Compared to 10 mm in Step-and-Shoot IMRT of HNC Using Integrated Boost Procedure

Christian Thieke, Simeon Nill, Jürgen Debus, 2010, Strahlentherapie und Onkologie.

IMRT and cetuximab in stage 3 non-small cell lung cancer: The NEAR trial (NCT00115518)

J. Debus, K. Herfarth, U. Haberkorn, 2007 .

J. Debus, J. Werner, A. Kopp-Schneider, 2012, BMC Cancer.

Blockade of TGF-beta signaling by the TGF β R-I kinase Inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma

J. Debus, M. Röhrich, A. Martin-Villalba, 2011 .

Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer

J. Debus, N. Nicolay, P. Huber, 2014, Radiation Oncology.

Intensity modulated radiotherapy (IMRT) in benign giant cell tumors--a single institution case series and a short review of the literature.

C. Thieke, J. Debus, M. Bischof, 2010, Radiation oncology.

600 poster POSTPLANNING OF A THREE-DIMENSIONAL DOSE DISTRIBUTION FOR INTRAOPERATIVE ELECTRON RADIATION THERAPY (IOERT) USING INTRAOPERATIVE C-ARM BASED 3D-IMAGING : A PHANTOM STUDY

J. Debus, A. Schwahofer, P. Huber, 2011 .

A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer

M. Koch, M. Büchler, J. Debus, 2011, BMC Cancer.

Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer

M. Koch, J. Debus, J. Weitz, 2011, BMC Cancer.